ACADIA Pharmaceuticals Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 8 | $0.05 | $0.05 | $0.05 |
| Q2 2024 | 7 | $0.18 | $0.18 | $0.18 |
| Q3 2024 | 5 | $0.13 | $0.14 | $0.14 |
| Q4 2024 | 12 | -$0.08 | $0.79 | $0.23 |
| Q1 2025 | 4 | $0.02 | $0.03 | $0.03 |
| Q2 2025 | 2 | $0.12 | $0.18 | $0.14 |
| Q3 2025 | 2 | $0.13 | $0.19 | $0.15 |
| Q4 2025 | 2 | $0.19 | $0.29 | $0.23 |
ACADIA Pharmaceuticals Inc. Earnings Date And Information
ACADIA Pharmaceuticals Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $0.2 earnings per share for the quarter, topping analysts' consensus estimates of $0.14 by $0.06. The company had revenue of 250.40 M for the quarter and had revenue of 726.44 M for the year. ACADIA Pharmaceuticals Inc. has generated $0 earnings per share over the last year ($-0.37 diluted earnings per share) and currently has a price-to-earnings ratio of 21.44. ACADIA Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
ACADIA Pharmaceuticals Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | $0.20 | $248.83 M | $250.40 M | ||
| 08/06/2024 | Q2 2024 | $0.20 | $235.95 M | $241.96 M | ||
| 05/08/2024 | Q1 2024 | $0.10 | $205.83 M | |||
| 12/30/2023 | Q4 2023 | $0.28 | $231.04 M | |||
| 11/02/2023 | Q3 2023 | -$0.40 | $192.32 M | $211.70 M | ||
| 08/02/2023 | Q2 2023 | $0.01 | $166.18 M | $165.24 M | ||
| 05/08/2023 | Q1 2023 | -$0.21 | -$0.27 | -0.06 | $118.46 M | |
| 02/27/2023 | Q4 2022 | -$0.26 | $136.49 M | |||
| 11/02/2022 | Q3 2022 | -$0.17 | $138.76 M | $130.71 M | ||
| 08/08/2022 | Q2 2022 | -$0.21 | $130.41 M | $134.56 M | ||
| 05/04/2022 | Q1 2022 | -$0.70 | $115.47 M | |||
| 03/01/2022 | Q4 2021 | -$0.27 | $130.76 M | |||
| 11/08/2021 | Q3 2021 | -$0.09 | $127.93 M | $131.61 M | ||
| 08/04/2021 | Q2 2021 | -$0.27 | $124.90 M | $115.22 M | ||
| 05/05/2021 | Q1 2021 | -$0.42 | $106.55 M | |||
| 02/24/2021 | Q4 2020 | -$0.42 | $121.01 M | |||
| 11/04/2020 | Q3 2020 | -$0.38 | -$0.54 | -0.16 | $118.82 M | $120.58 M |
| 08/05/2020 | Q2 2020 | -$0.27 | $103.41 M | $110.10 M | ||
| 05/07/2020 | Q1 2020 | -$0.57 | $90.07 M | |||
| 02/26/2020 | Q4 2019 | -$0.34 | $98.33 M |
ACADIA Pharmaceuticals Inc. Earnings: Frequently Asked Questions
-
When is ACADIA Pharmaceuticals Inc.'s earnings date?
ACADIA Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates.
-
Did ACADIA Pharmaceuticals Inc. beat their earnings estimates last quarter?
In the previous quarter, ACADIA Pharmaceuticals Inc. (:ACAD) reported $0.2 earnings per share (EPS) to beat the analysts' consensus estimate of $0.14 by $0.06.
-
How can I listen to ACADIA Pharmaceuticals Inc.'s earnings conference call?
The conference call for ACADIA Pharmaceuticals Inc.'s latest earnings report can be listened to online.
-
How can I read ACADIA Pharmaceuticals Inc.'s conference call transcript?
The conference call transcript for ACADIA Pharmaceuticals Inc.'s latest earnings report can be read online.
-
How much revenue does ACADIA Pharmaceuticals Inc. generate each year?
ACADIA Pharmaceuticals Inc. (:ACAD) has a recorded annual revenue of $726.44 M.
-
How much profit does ACADIA Pharmaceuticals Inc. generate each year?
ACADIA Pharmaceuticals Inc. (:ACAD) has a recorded net income of $726.44 M. ACADIA Pharmaceuticals Inc. has generated $-0.37 earnings per share over the last four quarters.
-
What is ACADIA Pharmaceuticals Inc.'s price-to-earnings ratio?
ACADIA Pharmaceuticals Inc. (:ACAD) has a price-to-earnings ratio of 21.44 and price/earnings-to-growth ratio is 0.06.
